• 제목/요약/키워드: protamine

검색결과 53건 처리시간 0.027초

체외순환중 용량반응곡선을 이용한 헤파린과 프로타민 투여량의 결정 (Individualization of Heparin and Protamine Dosage using a Dose-response Curve during Extracorporeal Circulation)

  • 원용순;노준량
    • Journal of Chest Surgery
    • /
    • 제24권3호
    • /
    • pp.253-260
    • /
    • 1991
  • The adequacy of anticoagulation with heparin during cardiopulmonary bypass, and precise neutralization with protamine at the conclusion of cardiopulmonary bypass, were important. In sixty children undergoing cardiopulmonary bypass, ACT and heparin dose-response curve were studied. Total dose of heparin before bypass were 2.80$\pm$0.74 mg/kg and the amount of protamine administered after bypass were 3.0$\pm$1.23 mg/kg. So protamine: heparin ratio was 1.07: l.c After administration of protamine which dose is calculated with heparin dose-response curve, ACTs were returned to normal range[mean 114.8 $\pm$13 second]. The heparin sensitivity and its half-life do not have relationship with age, weight, height, surface area and urine amount during operation. And there are too much individual variations in heparin sensitivity and its half-life. So conventional heparin protocols can overestimate or underestimate the amount of heparin and protamine. Heparin dose-response curve makes it possible to maintain anticoagulation in a safe range during bypass with adequate amount of heparin individually. At the conclusion of bypass, this curve can be used to predict the precise amount of protamine amount of protamine needed for neutralization of the heparin. But heparin dose-response curve to be used clinically, further studies will be needed about relationship between ACT and heparin level in the high range, influence of hemodilution and hypothermia to ACT and discrepancy between true adequate amount of protamine and calculated amount by heparin dose-response curve.

  • PDF

Effect of dietary protamine on lipid metabolism in ruts

  • Hosomi, Ryota;Fukunaga, Kenji;Arai, Hirofumi;Kanda, Seiji;Nishiyama, Toshimasa;Yoshida, Munehiro
    • Nutrition Research and Practice
    • /
    • 제4권6호
    • /
    • pp.462-469
    • /
    • 2010
  • Protamine has been widely used as a pharmaceutical product and natural food preservative. However, few studies have been conducted to assess the beneficial function of dietary protamine. This study examined the effects of dietary salmon protamine on serum and liver lipid levels and the expression levels of genes encoding proteins involved in lipid homeostasis in the liver of rats. Groups of male Wistar rats were fed AIN93G diet containing 2% or 5% protamine. After 4 weeks of feeding these diets, markedly decreased serum and liver cholesterol (CHOL) and triacylglycerol levels were noted. Increased activity of liver carnitine palmitoyltransferase-2 and acyl-CoA oxidase, which are key enzymes of fatty acid ${\beta}$-oxidation in the mitochondria and peroxisomes, was found in rats fed on protamine. Furthermore, rats fed protamine showed enhanced fecal excretion of CHOL and bile acid and increased liver mRNA expression levels of ATP-binding cassette (ABC) G5 and ABCG8, which form heterodimers and play a major role in the secretion of CHOL into bile. The decrease in triacylglycerol levels in protamine-fed rats was due to the enhancement of liver ${\beta}$-oxidation. Furthermore, rats fed protamine exhibited decreased CHOL levels through the suppression of CHOL and bile acid absorption and the enhancement of CHOL secretion into bile. These results suggest that dietary protamine has beneficial effects that may aid in the prevention of lifestyle-related diseases such as hyperlipidemia and atherosclerosis.

Heparin-Protamin Sulfate 상호작용의 실험적 연구

  • 김치경;이홍균
    • Journal of Chest Surgery
    • /
    • 제13권1호
    • /
    • pp.13-20
    • /
    • 1980
  • Heparin would have been used for preventing clotting of blood during extracorporeal circulation and subsequent use of protamine sulfate and made possible the neutralization of heparin. This procedure has been adopted for eliminating one of the great causes of bleeding, especially in cardiac surgery. In this experiment, the hypocoagulability of blood induced by heparin followed by neutralization with treatment of protamine sulfate were estimated by the Lee-White clotting time [CT], partial thromboplastin time [PTT] and protamine titration test. The results were as follows: 1] Comparison of clotting time between the heparinized [2.0 mg/kg] and non-heparinized dogs was done using CT and PT`I` of the blood. In heparinized group [Group I], the CT lasted infinitively and prolongation of PTT [4 times than normal] until 60 minutes. The CT [2 times] and PTT [3 times] has been shortened after 90 minutes, however they returned to normal limit level within 180 minutes. 2] The determination of appropriate ratio of heparin and protamine In vivo were performed. The group II [heparin 2.0 mg/kg, protamine 1.0 mg/kg] revealed rapid decrease of CT and PTT, but returned to normal after 120 minutes. The group III [heparin 2.0 mg/kg, protamine 2.0 mg/kg] returned rapidly to normal within 15 minutes. The group IV [heparin 2.0 mg/kg, protamine 3.0 mg/kg] recovered its normal level after 60 minutes. The group V [heparin 2.0 mg/kg, protamine 4.0 mg/kg] recovered its normal level after 90 minutes. 3] In the combined experimental study In vivo and vitro, the protamine titration test was done using the dog which were given 2.0 mg/kg and 3.0 mg/kg of heparin, respectively and coagulation time were checked after 15, 30, 60 and 120 minutes. The complete neutralization was showed to be heparin-protamine ratio of 1:1 to 1.5. 4] In vitro study, fresh blood was drawn into known amount of heparin content [20, 40, 60 and 100/ug per 1 ml of blood] syringe, thereafter protamine titration test was done. In all cases, the complete neutralization was found in heparin-protamine ratio of 1:0.85 to 1.5. 5] It was found by the present experiment that the ideal heparin-protamine ratio was 1:1 within 60 minutes and 1:0.5 after 60 minutes for avoiding the serious side effect due to overadministration of protamine sulfate.

  • PDF

Adverse Reactions to Protamine Sulfate used for Heparin Neutralization in a Dog Receiving a Blood Transfusion

  • Bae, Seulgi;Yun, Sungho;Oh, Taeho
    • 한국임상수의학회지
    • /
    • 제34권3호
    • /
    • pp.197-199
    • /
    • 2017
  • A 14-year-old castrated male ShihTzu diagnosed with chronic kidney disease (CKD) 6 months prior was referred to our clinic. The patient had been experiencing symptoms such as vomiting, poor appetite and hind limbs weakness. Hematology tests showed that he had a non-regenerative anemia. With aggressive treatment, the patient's state had gotten worse. He showed ragged breath, vomiting blood and loss of consciousness temporarily. Hematocrit maintained low level. Gastric hemorrhage was strongly suspected by hematemesis. Whole blood transfusion was performed and heparin was used as an anticoagulant. Prior to transfusion, the blood cross matching between donor and patient was performed and the result was compatible. After the transfusion was stabilized, 1 mg of protamine sulfate for each 100 units of heparin was prepared and given intravenously over 3 minutes to reverse the effects of heparin. Immediately after protamine injection, the patient conducted severe anaphylactic shock. Protamine sulfate is used to reverse the anticoagulant action of heparin in dogs and humans. The adverse reaction of protamine sulfate range from mild reaction to fetal cardiac arrest. When using protamine sulfate as heparin neutralization, it can lead to the death of a patient cause of anaphylactic shock. For this reason, the protamine sulfate should be injected slowly with antihistamine and the clinician should carefully monitor patients.

참치백자로부터 추출한 Protamine 의 특성 및 항균활성 (Antimicrobial Activity and Characteristics of Protamine Extracted from Tuna Spermary)

  • 전태욱;김진호;박기문
    • 한국식품과학회지
    • /
    • 제31권2호
    • /
    • pp.540-546
    • /
    • 1999
  • 참치 백자의 항균제호서의 사용 가능성 검토를 위하여 참치 백자의 특성 및 항균력 실험을 하였다. 아미노산 분석결과 arginine 함량은 약 46%로 연어 백자로부터 추출한 standard protamine (SP, Asama 화성, Japan)에 비해 약 10%가 낮았으며, proline및 glycine등 아미노산 조성에서도 큰 차이가 있었다. 주된 단백질의 평균 분자량은 SP가 11,300 Da과 2,600 Da이었으며, TP는 13,400 Da이었다. 그리고 SP와 TP의 항균활성 비교 실험에서 TP는 SP보다 약한 것으로 나타났다. 항균활성을 높이기 위해 $37^{\circ}C$에서 효소처리한 pepsine hydrolyzed protamine (PHP)과 trypsine hydrolyzed protamine (THP)의 주된 단백질의 평균 분자량은 PHP의 경우 11,300 Da과 3,900 Da으로 확인되었고, THP의 분자량은 2,500 Da 이하로 나타났다. PHP의 항균활성을 확인한 결과 TP보다 높은 항균력을 보였으며, 주된 단백질의 평균 분자량이 비슷한 SP와 유사하게 항균활성이 향상됨을 알 수 있었다. 그러나 gram (+)균인 Stap. aureus, L. helveticus, L. plantarum 등에서는 PHP가 SP보다 강한 항균활성을 보여 주었다. 그리고 분자량이 2,500 Da 이하인 THP의 경우 항균활성이 없는 것으로 밝혀졌다. 이와같이 PHP의 항균활성이 향상된 것은 protamine의 arginine의 함량이 증가하지 않더라도 주된 단백질의 평균 분자량이 변화되었기 때문으로 생각된다. 따라서 참치 백자로부터 추출한 TP를 pepsin처리했을 때 SP와 유사한 수준으로 항균활성 향상되는 것을 확인하였다.

  • PDF

체외순환 후 에 의해 유발된 아나필락시스 반응 - 1예 보고- (Protamine Induced Anaphylactic Reaction after Cardiopulmonary Bypass -A case report-)

  • 백종현;한승세;이정철;정태은;이장훈;이동협
    • Journal of Chest Surgery
    • /
    • 제37권7호
    • /
    • pp.606-608
    • /
    • 2004
  • 체외순환 후 heparin의 항응고효과를 중화시키기 위해 널리 사용되는 protamine에 대한 아나필락시스 반응은 매우 드물다. 하지만 그 결과는 매우 치명적일 수 있으며, 아직도 정확한 발생기전이 알려져 있지 않다. 당뇨병이 없는 57세 여자 환자가 승모판막 치환술 및 극초단파(Microwave)를 이용한 Maze 술식을 시행 받은 후 protamine에 의한 심각한 아나필락시스 반응이 발생하여 증례 보고하는 바이다.

개심술시 Activated Clotting Time 을 이용한 Heparin 및 Protamine 양 조절에 관한 임상적 관찰 (Monitoring of Heparin and Protamine Therapy by Activated Clotting Time During Open-Heart Surgery)

  • 김춘동;이성행
    • Journal of Chest Surgery
    • /
    • 제13권4호
    • /
    • pp.346-355
    • /
    • 1980
  • It has been proposed that wide individual variation in response to heparin be not considered in the conventional set protocol for the control of heparin and protamine during extracorporeal circulation. In this paper, two protocol of heparin and protamine therapy were compared to assess the role of the Activated Clotting Time [ACT] in relation to heparin, protamine, and postoperative blood loss and transfusion. The study groups consisted of the 31 patients [adults 15 and children 16] anticoagulated with the conventional heparin protocol and the 31 patients [adults 15 and children 16] anticoagulated with ACT protocol during extracorporeal circulation. In the conventional heparin protocol, two mg of heparin per kg was administered initially with an additional 0.75 mg of heparin per kg every 30 minutes of extracorporeal circulation, and reversal was accomplished with protamine in a dose of 1.5 times the total milligram of heparin. In the ACT protocol, two mg of heparin per kg was administered initially with an additional dose of heparin enough to reach an ACT of 480 seconds [within safe zone 300 to 600 seconds] from the patient`s dose response curve every 1 hour of extracorporeal circulation, and reversal was done with protamine in a dose of 1.3 times the milligram of the residual heparin. The results were summarized as follows. After a dose of 2 mg per kg of heparin, the patient`s ACT varied from 240 to 600 seconds in adults and from 240 t~ 660 seconds in children. In the ACT group the total amount of heparin administered was markedly reduced when compared to the conventional group, and less protamine was required to neutralize heparin. The dose of heparin administered decreased from 7.07 [SE 0.42] mg/kg of the conventional group to 4.92 [SE 0.32] mg/k8 of the ACT group in adults and from 10.17 [SE 1.15] mg/kg to 5.23 [SE 0.24] mg/kg in children, which represent 30.4% and 48.6% decrease respectively. The dose of protamine administered for reversal decreased from 10.6 [SE 0.63] mg/kg of the conventional group to 3.35 [SE 0.35] mg/kg of the ACT group in adults and from 15.7 [SE 1.70] mg/kg to 3.26 [SE 0.27] mg/kg in children, which represent 68.4% and 79.2% respectively. The ratio of protamine to heparin administered in the conventional group was 1.50:1 in adults and 1.54:1 in children, but in the ACT group 0.68:1 in adults and 0.62:1 in children. Postoperative blood loss and transfusion revealed no statistically significant difference between the two groups. Although six patients in the conventional group and one in the ACT group needed re-exploration for continuous hemorrhage, no case of generalized oozing was encountered, and in each case a definite bleeding site was identified. Author would like emphasizing the value of the ACT protocol in controlling heparin and protamine administration during extracorporeal circulation.

  • PDF

Protamin 투여로 야기되는 혈역학적 변화에 미치는 Indomethacin 의 영향 (The effect of indomethacin on the protamine induced hemodynamic changes)

  • 김경우;조건현;이홍균
    • Journal of Chest Surgery
    • /
    • 제23권2호
    • /
    • pp.222-230
    • /
    • 1990
  • Protamine, a polycationic peptide extracted from fish, has been widely used for the reversal of anticoagulant action of heparin. However it may cause untoward circulatory side effects including hypotension and bradyarrhythmia. Nowadays, histamine and prostacyclin are regarded as one of the causative agents in the underlying mechanism of hemodynamic changes. To certify the possible role of histamine and prostacyclin, we observed simultaneous changes of the hemodynamic status, plasma concentration of thromboxane B, and circulating platelet count before and after intravenous injection of protamine. Experimental dogs, weighing 12-14kg, were divided into 2 groups; group A animals [n=10], were pretreated with indomethacin[2.5mg/kg] and group B animals[n=10] were pretreated with chlorpheniramine[0.5mg/kg] Heparin[3mg/kg] and protamine [3mg/kg] were administered sequentially in both groups. The results were as follows ; 1. The mean systemic arterial pressure was maintained well in groups A, whereas in group B it decreased from 165\ulcorner18mmHg to 138\ulcorner30mmHg[p<0.01] and 151\ulcorner21 mmHg[p<0.05] at 1 minute and 2 minutes after protamine injection. The mean pulmonary arterial pressure was not changed significantly in group A, whereas in group B it increased from 852 mmHg to 11\ulcorner3 mmHg[p<0.05], 11\ulcorner3 mmHg[p<0.05] and 10\ulcorner3 mmHg[p<0.05] at 1 minute, 3 minutes and 5 minutes after protamine injection. 2 The thromboxane B2 was not changed significantly in group A, whereas in group B it increased from 399\ulcorner401 \ulcornerg/ml to 744\ulcorner615 \ulcornerg/ml[p<0.05] and 814\ulcorner1070 \ulcornerg/ml [p<0.0 5] at 1 minute and 3 minutes after protamine injection without concomitant changes of pulmonary vascular resistance and pulmonary capillary wedge pressure. 3. The number of circulating platelet was not changed in group A, whereas in group B it decreased from 207100\ulcorner103600/\ulcornerl to 159700\ulcorner90900/\ulcornerl [p<0.05] at 1 minute after protamine injection, Although thromboxane B2 and platelet count were changed significantly after protamine injection, they did not cause the remarkable hemodynamic changes. Considering the above results, hemodynamic changes may be caused mainly by prostacyclin rather than thromboxane or platelet. Therefore, the pretreatment with cyclooxygenase inhibitor would be beneficial to prevent circulatory adverse effects of protamine for the patients undergoing cardiac surgery.

  • PDF

Catastrophic Bronchial Spasm Due to a Severe Anaphylactic Reaction to Protamine

  • Kim, Jae-Bum;Kim, Jae Hyun;Song, Kyung Sub
    • Journal of Chest Surgery
    • /
    • 제49권6호
    • /
    • pp.472-474
    • /
    • 2016
  • Fatal anaphylactic reactions to protamine sulfate during cardiac surgery are very rare. We report a case of catastrophic bronchial spasm due to an anaphylactic reaction to protamine. The patient was managed successfully using a bronchodilator, steroid treatment, and extracorporeal membrane oxygenation.

체외 순환시간의 경과에 따른 Heparin과 Protamine의 적정량에 관한 연구 (Adequate Heparin-protamine Neutralization on using Blood Cardioplegic Solution during Extracorporeal Circulation)

  • 변형섭
    • Journal of Chest Surgery
    • /
    • 제21권2호
    • /
    • pp.203-210
    • /
    • 1988
  • The clinical experience with the activated clotting time[A.C.T.] for the control of heparin and protamine therapy during cardiopulmonary bypass in 40 patients between April, 1987 and September, 1987 is reviewed retrospectively. All of patients used with cold blood potassium cardioplegia for myocardial protection under standard cardiopulmonary bypass, priming and perfusate techniques respectively. This study was divided into 2 groups of patients followed by cardiopulmonary bypass time. Twenty patients, within 60 minutes of cardiopulmonary bypass time[group A] were compared with twenty patients, from 60 to 120 minutes of cardiopulmonary bypass time[group B]. Using blood cardioplegia for myocardial protection, Author observed wide variation of A.C.T. in individual response to initial heparinization[2mg /kg] and no requirement of additional heparin during cardiopulmonary bypass until 120 minutes. Total heparin amount during cardiopulmonary bypass was not related to body weight and body surface area in the both groups. After cardiopulmonary bypass, amounts of protamine for neutralization of heparin were more required in group B.

  • PDF